Cliff Asness's MLYS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 62,300 shares of Mineralys Therapeutics, Inc. (MLYS) worth $2.26 M, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Cliff Asness has maintained this position in MLYS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 44,178 shares. Largest reduction occurred in Q3 2025, reducing 9,779 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Mineralys Therapeutics (MLYS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Mineralys Therapeutics (MLYS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +44,178 | Add 243.78% | 62,300 | $36.29 |
| Q3 2025 | -9,779 | Reduce 35.05% | 18,122 | $37.92 |
| Q2 2025 | -6,714 | Reduce 19.40% | 27,901 | $13.53 |
| Q1 2025 | +34,615 | New Buy | 34,615 | $15.88 |
Cliff Asness's Mineralys Therapeutics Investment FAQs
Cliff Asness first purchased Mineralys Therapeutics, Inc. (MLYS) in Q1 2025, acquiring 34,615 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Mineralys Therapeutics, Inc. (MLYS) for 4 quarters since Q1 2025.
Cliff Asness's largest addition to Mineralys Therapeutics, Inc. (MLYS) was in Q4 2025, adding 62,300 shares worth $2.26 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 62,300 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $2.26 M.
As of the Q4 2025 filing, Mineralys Therapeutics, Inc. (MLYS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Mineralys Therapeutics, Inc. (MLYS) was 62,300 shares, as reported at the end of Q4 2025.